| Troy Edward Adolfson, MD | |
|
620 3rd Ave Se, Aberdeen, SD 57401-4554 | |
| (605) 622-5500 | |
| Not Available |
| Full Name | Troy Edward Adolfson |
|---|---|
| Gender | Male |
| Speciality | Radiology - Radiation Oncology |
| Location | 620 3rd Ave Se, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578794715 | NPI | - | NPPES |
| 1578794715 | Medicaid | WI | |
| 1578794715 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 51555 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Troy Edward Adolfson, MD Po Box 1460, Aberdeen, SD 57402-1460 Ph: (605) 622-2857 | Troy Edward Adolfson, MD 620 3rd Ave Se, Aberdeen, SD 57401-4554 Ph: (605) 622-5500 |
News Archive
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
McCormack Innovation, working alongside strategic partners including the University of Dundee to develop the world's first soluble medical dressings that will dissolve in seconds when immersed in water, has signed a significant supply agreement to the Yemen.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
› Verified 5 days ago
Jack Barnet Vonk, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 24-2nd Ave Sw, Aberdeen, SD 57401 Phone: 605-725-2560 | |
Sheryl A Siegmund, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 | |
Leslie H Lenter, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 | |
Caroline J Lundell, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 | |
Dr. Enrique Flores Mendoza, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5500 Fax: 605-622-5042 | |
Melchor J Aguilar, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 |